Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 125 articles:
HTML format
Text format



Single Articles


    August 2017
  1. KOSMIDOU I, Embacher M, McAndrew T, Dizon JM, et al
    Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31286.
    PubMed     Text format     Abstract available


  2. CHEN ST, Hellkamp AS, Becker RC, Berkowitz SD, et al
    Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in
    Am J Cardiol. 2017 Aug 7. pii: S0002-9149(17)31301.
    PubMed     Text format     Abstract available


    July 2017
  3. SHANTHA GPS, Mentias A, Bhise V, Kumar A, et al
    Gender Differences in the Trends of Hospitalizations for Acute Stroke Among Patients With Atrial Fibrillation in the United States: 2005 to 2014.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31217.
    PubMed     Text format     Abstract available


  4. CARROLL BJ, Pemberton H, Bauer KA, Chu LM, et al
    Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism.
    Am J Cardiol. 2017 Jul 26. pii: S0002-9149(17)31198.
    PubMed     Text format     Abstract available


  5. KHURSHID S, Weng LC, Hulme OL, Ellinor PT, et al
    Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31181.
    PubMed     Text format     Abstract available


  6. WIESEL J, Salomone TJ
    Screening for Atrial Fibrillation in Patients >/=65 Years Using an Automatic Blood Pressure Monitor in a Skilled Nursing Facility.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31180.
    PubMed     Text format     Abstract available


  7. SOLIMAN EZ, Zhang ZM, Judd S, Howard VJ, et al
    Comparison of Risk of Atrial Fibrillation Among Employed Versus Unemployed (from the REasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31165.
    PubMed     Text format     Abstract available


  8. LOIKAS D, Forslund T, Wettermark B, Schenck-Gustafsson K, et al
    Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non-Vitamin K Oral Anticoagulants.
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31166.
    PubMed     Text format     Abstract available


  9. ADMASSIE E, Chalmers L, Bereznicki LR
    Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31117.
    PubMed     Text format     Abstract available


  10. HONG C, Alluri K, Shariff N, Khattak F, et al
    Usefulness of the CHA2DS2-VASc Score to Predict Mortality in Defibrillator Recipients.
    Am J Cardiol. 2017;120:83-86.
    PubMed     Text format     Abstract available


    June 2017
  11. LIP GYH, Al-Saady N, Jin J, Sun M, et al
    Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30957.
    PubMed     Text format     Abstract available


  12. ASHBURNER JM, Singer DE, Lubitz SA, Borowsky LH, et al
    Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30956.
    PubMed     Text format     Abstract available


  13. SILBERBERG A, Tan MK, Yan AT, Angaran P, et al
    Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Netw
    Am J Cardiol. 2017 Jun 1. pii: S0002-9149(17)30863.
    PubMed     Text format     Abstract available


    May 2017
  14. WASHAM JB, Hellkamp AS, Lokhnygina Y, Piccini JP, et al
    Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
    Am J Cardiol. 2017 May 29. pii: S0002-9149(17)30862.
    PubMed     Text format     Abstract available


  15. LEMPEREUR M, Aminian A, Freixa X, Gafoor S, et al
    Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
    Am J Cardiol. 2017 May 12. pii: S0002-9149(17)30782.
    PubMed     Text format     Abstract available


  16. SHAH RR, Pillai A, Schafer P, Meggo D, et al
    Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.
    Am J Cardiol. 2017 May 10. pii: S0002-9149(17)30777.
    PubMed     Text format     Abstract available


  17. DE ASMUNDIS C, Mugnai G, Chierchia GB, Sieira J, et al
    Long-Term Follow-Up of Probands With Brugada Syndrome.
    Am J Cardiol. 2017;119:1392-1400.
    PubMed     Text format     Abstract available


  18. LEE MS, Park KW, Shlofmitz E, Shlofmitz RA, et al
    Comparison of Rotational Atherectomy Versus Orbital Atherectomy for the Treatment of Heavily Calcified Coronary Plaques.
    Am J Cardiol. 2017;119:1320-1323.
    PubMed     Text format     Abstract available


    April 2017
  19. LAUBE ES, Yu A, Gupta D, Miao Y, et al
    Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30697.
    PubMed     Text format     Abstract available


  20. MUGNAI G, de Asmundis C, Iacopino S, Stroker E, et al
    Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30700.
    PubMed     Text format     Abstract available


  21. DE HARO J, Michel I, Bleda S, Canibano C, et al
    Carotid Stenting in Patients With High Risk Versus Standard Risk for Open Carotid Endarterectomy (REAL-1 Trial).
    Am J Cardiol. 2017 Apr 26. pii: S0002-9149(17)30711.
    PubMed     Text format     Abstract available


  22. GOLIVE A, May HT, Bair TL, Jacobs V, et al
    The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30627.
    PubMed     Text format     Abstract available


    March 2017
  23. AGARWAL S, Sud K, Thakkar B, Menon V, et al
    Changing Trends of Atherosclerotic Risk Factors Among Patients With Acute Myocardial Infarction and Acute Ischemic Stroke.
    Am J Cardiol. 2017 Mar 31. pii: S0002-9149(17)30213.
    PubMed     Text format     Abstract available


  24. VELASQUEZ-RODRIGUEZ J, Diez-Delhoyo F, Valero-Masa MJ, Vicent L, et al
    Prognostic Impact of Age and Hemoglobin in Acute ST-Segment Elevation Myocardial Infarction Treated With Reperfusion Therapy.
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30341.
    PubMed     Text format     Abstract available


  25. BALLA SR, Cyr DD, Lokhnygina Y, Becker RC, et al
    Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30352.
    PubMed     Text format     Abstract available


  26. NGUYEN P, Kamran H, Nasir S, Chan W, et al
    Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine.
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30358.
    PubMed     Text format     Abstract available


  27. ELBADAWI A, Olorunfemi O, Ogunbayo GO, Saad M, et al
    Cardiovascular Outcomes With Surgical Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation Who Underwent Valvular Heart Surgery (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30361.
    PubMed     Text format     Abstract available


  28. STEINBERG BA, Simon DN, Thomas L, Ansell J, et al
    Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fib
    Am J Cardiol. 2017 Mar 28. pii: S0002-9149(17)30201.
    PubMed     Text format     Abstract available


  29. CHERIAN TS, Shrader P, Fonarow GC, Allen LA, et al
    Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30289.
    PubMed     Text format     Abstract available


  30. O'NEAL WT, Sandesara P, Hammadah M, Venkatesh S, et al
    Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30282.
    PubMed     Text format     Abstract available


  31. BOSE A, O'Neal WT, Bennett A, Judd SE, et al
    Relation Between Estimated Cardiorespiratory Fitness and Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30285.
    PubMed     Text format     Abstract available


    February 2017
  32. XIE JX, Glorioso TJ, Dattilo PB, Aggarwal V, et al
    Effect of Chronic Kidney Disease on Mortality in Patients Who Underwent Lower Extremity Peripheral Vascular Intervention.
    Am J Cardiol. 2017;119:669-674.
    PubMed     Text format     Abstract available


  33. BYKOV K, Schneeweiss S, Donneyong MM, Dong YH, et al
    Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors.
    Am J Cardiol. 2017;119:651-657.
    PubMed     Text format     Abstract available


  34. QIAN C, Feng H, Cao J, Wei B, et al
    Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing.
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30126.
    PubMed     Text format     Abstract available


  35. DIDIER R, Gaglia MA Jr, Lipinski MJ, Koifman E, et al
    Comparison of Baseline Characteristics and Inhospital Outcomes of Patients and Use of Bare Metal Versus Drug-Eluting Stents During Percutaneous Coronary Intervention 2005 to 2015 at a Single Tertiary Hospital.
    Am J Cardiol. 2017 Feb 9. pii: S0002-9149(17)30115.
    PubMed     Text format     Abstract available


    January 2017
  36. POLI D, Antonucci E, Pengo V, Testa S, et al
    Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jan 26. pii: S0002-9149(16)32003.
    PubMed     Text format     Abstract available


  37. ABE M, Ogawa H, Ishii M, Masunaga N, et al
    Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry).
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30054.
    PubMed     Text format     Abstract available


  38. COHEN R, Bavishi C, Haider S, Thankachen J, et al
    Meta-Analysis of Relation of Vital Exhaustion to Cardiovascular Disease Events.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30067.
    PubMed     Text format     Abstract available


  39. QI Z, Chen H, Wen Z, Yuan F, et al
    Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30055.
    PubMed     Text format     Abstract available


  40. SHERAZI S, Kutyifa V, McNitt S, Papernov A, et al
    Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist Devices.
    Am J Cardiol. 2017;119:297-301.
    PubMed     Text format     Abstract available


  41. MUSCARI A, Bonfiglioli A, Faccioli L, Ghinelli M, et al
    Usefulness of the MrWALLETS Scoring System to Predict First Diagnosed Atrial Fibrillation in Patients With Ischemic Stroke.
    Am J Cardiol. 2017 Jan 5. pii: S0002-9149(16)32005.
    PubMed     Text format     Abstract available


    December 2016
  42. NORTON L, Tsiperfal A, Cook K, Bagdasarian A, et al
    Effectiveness and Safety of an Independently Run Nurse Practitioner Outpatient Cardioversion Program (2009 to 2014).
    Am J Cardiol. 2016;118:1842-1846.
    PubMed     Text format     Abstract available


  43. FREIXA X, Llull L, Gafoor S, Cruz-Gonzalez I, et al
    Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion.
    Am J Cardiol. 2016;118:1836-1841.
    PubMed     Text format     Abstract available


  44. JONES PH, Bays HE, Chaudhari U, Pordy R, et al
    Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.
    Am J Cardiol. 2016;118:1805-1811.
    PubMed     Text format     Abstract available


  45. PEACOCK WF, Tamayo S, Sicignano N, Hopf KP, et al
    Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
    Am J Cardiol. 2016 Dec 9. pii: S0002-9149(16)31892.
    PubMed     Text format     Abstract available


  46. BRASCIA D, Reichart D, Onorati F, Perrotti A, et al
    Validation of Bleeding Classifications in Coronary Artery Bypass Grafting.
    Am J Cardiol. 2016 Dec 3. pii: S0002-9149(16)31896.
    PubMed     Text format     Abstract available


  47. LIP GY, Waldo AL, Ip J, Martin DT, et al
    Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Am J Cardiol. 2016;118:1680-1684.
    PubMed     Text format     Abstract available


    November 2016
  48. GUO L, Li S, Wang P, Zhong X, et al
    Comparative Efficacy of Clinical Events Prevention of Five Anticoagulants in Patients With Atrial Fibrillation (A Network Meta-Analysis).
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31817.
    PubMed     Text format     Abstract available


  49. SUN Y, Liu X, He Y, Tang M, et al
    Meta-Analysis of Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31824.
    PubMed     Text format     Abstract available


  50. BANGALORE S, Fayyad R, Messerli FH, Laskey R, et al
    Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
    Am J Cardiol. 2016 Nov 4. pii: S0002-9149(16)31749.
    PubMed     Text format     Abstract available


  51. KARUNANITHI Z, Nyboe C, Hjortdal VE
    Long-Term Risk of Atrial Fibrillation and Stroke in Patients With Atrial Septal Defect Diagnosed in Childhood.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31726.
    PubMed     Text format     Abstract available


  52. GARG L, Agrawal S, Pew T, Hanzel GS, et al
    Psoas Muscle Area as a Predictor of Outcomes in Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31730.
    PubMed     Text format     Abstract available


    October 2016
  53. OHYA M, Kadota K, Toyofuku M, Morimoto T, et al
    Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
    Am J Cardiol. 2016 Oct 31. pii: S0002-9149(16)31744.
    PubMed     Text format     Abstract available


  54. BENJAMIN MM, Chaddha A, Sampene E, Field ME, et al
    Comparison of Outcomes of Atrial Fibrillation in Patients With Reduced Versus Preserved Left Ventricular Ejection Fraction.
    Am J Cardiol. 2016 Oct 11. pii: S0002-9149(16)31489.
    PubMed     Text format     Abstract available


  55. MARTIN RC, Burgin WS, Schabath MB, Kirby B, et al
    Gender-Specific Differences for Risk of Disability and Death in Atrial Fibrillation-Related Stroke.
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31621.
    PubMed     Text format     Abstract available


  56. HELLYER JA, Azarbal F, Than CT, Fan J, et al
    Impact of Baseline Stroke Risk and Bleeding Risk on Warfarin International Normalized Ratio Control in Atrial Fibrillation (from the TREAT-AF Study).
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31617.
    PubMed     Text format     Abstract available


  57. MOREYRA AE, Maniatis GA, Gu H, Swerdel JN, et al
    Frequency of Stroke After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting (from an Eleven-Year Statewide Analysis).
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31618.
    PubMed     Text format     Abstract available


    September 2016
  58. VARMDAL T, Janszky I, Bakken IJ, Ellekjaer H, et al
    Percutaneous Coronary Intervention as a Trigger for Stroke.
    Am J Cardiol. 2016 Sep 29. pii: S0002-9149(16)31571.
    PubMed     Text format     Abstract available


  59. CODNER P, Levi A, Gargiulo G, Praz F, et al
    Impact of Renal Dysfunction on Results of Transcatheter Aortic Valve Replacement Outcomes in a Large Multicenter Cohort.
    Am J Cardiol. 2016 Sep 15. pii: S0002-9149(16)31498.
    PubMed     Text format     Abstract available


  60. DAWOOD FZ, Judd S, Howard VJ, Limdi NA, et al
    High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2016 Sep 14. pii: S0002-9149(16)31476.
    PubMed     Text format     Abstract available


  61. MAKAM RC, Erskine N, McManus DD, Lessard D, et al
    Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31472.
    PubMed     Text format     Abstract available


    August 2016
  62. LO JY, Minich LL, Tani LY, Wilkes J, et al
    Factors Associated With Resource Utilization and Coronary Artery Dilation in Refractory Kawasaki Disease (from the Pediatric Health Information System Database).
    Am J Cardiol. 2016 Aug 31. pii: S0002-9149(16)31430.
    PubMed     Text format     Abstract available


  63. THANOPOULOS BV, Ninios V, Dardas P, Giannopoulos A, et al
    Catheter Closure Through a Venous Approach of Patent Ductus Arteriosus in Small Pediatric Patients Using Combined Angiographic and Echocardiographic Guidance.
    Am J Cardiol. 2016 Aug 23. pii: S0002-9149(16)31383.
    PubMed     Text format     Abstract available


  64. TRZECIAK P, Wozakowska-Kaplon B, Niedziela J, Gierlotka M, et al
    Comparison of Inhospital and 12- and 36-Month Outcomes After Acute Coronary Syndrome in Men Versus Women <40 Years (from the PL-ACS Registry).
    Am J Cardiol. 2016 Aug 12. pii: S0002-9149(16)31337.
    PubMed     Text format     Abstract available


  65. KOHLI P, Knowles JW, Sarraju A, Waters DD, et al
    Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials).
    Am J Cardiol. 2016 Aug 12. pii: S0002-9149(16)31324.
    PubMed     Text format     Abstract available


  66. BIAGINI E, Pazzi C, Olivotto I, Musumeci B, et al
    Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2016;118:432-9.
    PubMed     Text format     Abstract available


    July 2016
  67. PATEL NJ, Pau D, Nalluri N, Bhatt P, et al
    Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31234.
    PubMed     Text format     Abstract available


  68. MURALIDHARAN A, Thiagarajan K, Van Ham R, Gleason TG, et al
    Meta-Analysis of Perioperative Stroke and Mortality in Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Jul 18. pii: S0002-9149(16)31181.
    PubMed     Text format     Abstract available


  69. TAKAHASHI H, Jimbo Y, Takano H, Abe H, et al
    Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Am J Cardiol. 2016;118:222-5.
    PubMed     Text format     Abstract available


  70. ATHER S, Shendre A, Beasley TM, Brown T, et al
    Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.
    Am J Cardiol. 2016;118:232-6.
    PubMed     Text format     Abstract available


    June 2016
  71. WONG CX, Odutayo A, Emdin CA, Kinnear NJ, et al
    Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.
    Am J Cardiol. 2016;117:1934-41.
    PubMed     Text format     Abstract available


  72. QUINN GR, Singer DE, Chang Y, Go AS, et al
    How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?
    Am J Cardiol. 2016 Jun 15. pii: S0002-9149(16)31035.
    PubMed     Text format     Abstract available


  73. FAUCHIER L, Lecoq C, Ancedy Y, Stamboul K, et al
    Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting.
    Am J Cardiol. 2016 Jun 14. pii: S0002-9149(16)31039.
    PubMed     Text format     Abstract available


    May 2016
  74. HANSEN GM, Egeberg A, Holmstrup P, Hansen PR, et al
    Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (from a Danish Nationwide Cohort Study).
    Am J Cardiol. 2016 May 30. pii: S0002-9149(16)30939.
    PubMed     Text format     Abstract available


  75. SKELDING KA, Yakubov SJ, Kleiman NS, Reardon MJ, et al
    Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30954.
    PubMed     Text format     Abstract available


  76. EMDIN CA, Odutayo A, Wong CX, Tran J, et al
    Meta-Analysis of Anxiety as a Risk Factor for Cardiovascular Disease.
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30944.
    PubMed     Text format     Abstract available


  77. FORREST JK, Adams DH, Popma JJ, Reardon MJ, et al
    Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials).
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30867.
    PubMed     Text format     Abstract available


  78. SWAMINATHAN RV, Feldman DN, Pashun RA, Patil RK, et al
    Gender Differences in In-Hospital Outcomes After Coronary Artery Bypass Grafting.
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30858.
    PubMed     Text format     Abstract available


  79. JACOBS V, May HT, Bair TL, Crandall BG, et al
    Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30561.
    PubMed     Text format     Abstract available


  80. MOON J, Suh J, Oh PC, Lee K, et al
    Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30568.
    PubMed     Text format     Abstract available


  81. HECHT EM, Arheart KL, Lee DJ, Hennekens CH, et al
    Interrelation of Cadmium, Smoking, and Cardiovascular Disease (from the National Health and Nutrition Examination Survey).
    Am J Cardiol. 2016 May 4. pii: S0002-9149(16)30560.
    PubMed     Text format     Abstract available


    April 2016
  82. PROIETTI M, Lane DA, Lip GY
    Relation of Nonvalvular Atrial Fibrillation to Body Mass Index (from the SPORTIF Trials).
    Am J Cardiol. 2016 Apr 21. pii: S0002-9149(16)30494.
    PubMed     Text format     Abstract available


  83. GOKSULUK H, Gulec S, Ozcan OU, Gerede M, et al
    Usefulness of Neuron-Specific Enolase to Detect Silent Neuronal Ischemia After Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Apr 6. pii: S0002-9149(16)30424.
    PubMed     Text format     Abstract available


  84. MAIN ML, Fan D, Reddy VY, Holmes DR, et al
    Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
    Am J Cardiol. 2016;117:1127-34.
    PubMed     Text format     Abstract available


    March 2016
  85. LEIGH JA, O'Neal WT, Soliman EZ
    Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged >/=65 Years.
    Am J Cardiol. 2016 Mar 19. pii: S0002-9149(16)30366.
    PubMed     Text format     Abstract available


  86. CHENG EY, Kong MH
    Gender Differences of Thromboembolic Events in Atrial Fibrillation.
    Am J Cardiol. 2016;117:1021-7.
    PubMed     Text format     Abstract available


  87. MOSTAFA A, Briasoulis A, Telila T, Belgrave K, et al
    Treatment of Massive or Submassive Acute Pulmonary Embolism With Catheter-Directed Thrombolysis.
    Am J Cardiol. 2016;117:1014-20.
    PubMed     Text format     Abstract available


    January 2016
  88. DEL-CARPIO MUNOZ F, Gharacholou SM, Munger TM, Friedman PA, et al
    Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation.
    Am J Cardiol. 2016;117:69-75.
    PubMed     Text format     Abstract available


  89. FREIXA X, Gafoor S, Regueiro A, Cruz-Gonzalez I, et al
    Comparison of Efficacy and Safety of Left Atrial Appendage Occlusion in Patients Aged <75 to >/= 75 Years.
    Am J Cardiol. 2016;117:84-90.
    PubMed     Text format     Abstract available


    December 2015
  90. WU S, Yang YM, Zhu J, Wan HB, et al
    Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    Am J Cardiol. 2015 Dec 30. pii: S0002-9149(15)30072.
    PubMed     Text format     Abstract available


  91. ANDERSON JL, May HT, Lappe DL, Bair T, et al
    Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
    Am J Cardiol. 2015 Dec 13. pii: S0002-9149(15)02353.
    PubMed     Text format     Abstract available


    November 2015
  92. SCHWARTZENBERG S, Lev EI, Sagie A, Korzets A, et al
    The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease.
    Am J Cardiol. 2015 Nov 19. pii: S0002-9149(15)02258.
    PubMed     Text format     Abstract available


  93. CIPRIANO LE, Sposato LA
    Usefulness of Holter Monitoring for Detecting Atrial Fibrillation After Stroke or Transient Ischemic Attack.
    Am J Cardiol. 2015 Nov 11. pii: S0002-9149(15)02217.
    PubMed     Text format    


  94. WEISSLER-SNIR A, Weisenberg D, Natanzon S, Bental T, et al
    Clinical and Echocardiographic Features of Mitral Annular Calcium in Patients Aged </=50 Years.
    Am J Cardiol. 2015;116:1447-50.
    PubMed     Text format     Abstract available


    October 2015
  95. YONG C, Azarbal F, Abnousi F, Heidenreich PA, et al
    Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
    Am J Cardiol. 2015 Oct 22. pii: S0002-9149(15)02085.
    PubMed     Text format     Abstract available


    September 2015
  96. SZYMANSKI FM, Lip GY, Filipiak KJ, Platek AE, et al
    Stroke Risk Factors Beyond the CHADS-VASc Score: Can We Improve Our Identification of "High Stroke Risk" Patients With Atrial Fibrillation?
    Am J Cardiol. 2015 Sep 11. pii: S0002-9149(15)01935.
    PubMed     Text format     Abstract available


    July 2015
  97. O'NEAL WT, Qureshi WT, Judd SE, Bowling CB, et al
    Effect of Falls on Frequency of Atrial Fibrillation and Mortality Risk (from the REasons for Geographic And Racial Differences in Stroke Study).
    Am J Cardiol. 2015 Jul 29. pii: S0002-9149(15)01696.
    PubMed     Text format     Abstract available


  98. NAGARAKANTI R, Wallentin L, Noack H, Brueckmann M, et al
    Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).
    Am J Cardiol. 2015 Jul 28. pii: S0002-9149(15)01692.
    PubMed     Text format     Abstract available


  99. WAKSMAN R
    Reply: To PMID 25579887.
    Am J Cardiol. 2015;116:335-6.
    PubMed     Text format    


  100. STOLLBERGER C, Finsterer J, Schneider B
    Problems in addition to stroke and bleeding after left atrial appendage closure.
    Am J Cardiol. 2015;116:335.
    PubMed     Text format    


    June 2015
  101. ELEID MF, Goel K, Murad MH, Erwin PJ, et al
    Meta-analysis of the Prognostic Impact of Stroke Volume, Gradient, and Ejection Fraction After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2015 Jun 26. pii: S0002-9149(15)01545.
    PubMed     Text format     Abstract available


  102. CHOE WC, Passman RS, Brachmann J, Morillo CA, et al
    A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial).
    Am J Cardiol. 2015 Jun 24. pii: S0002-9149(15)01526.
    PubMed     Text format     Abstract available


  103. YE S, Cheng B, Lip GY, Buchsbaum R, et al
    Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
    Am J Cardiol. 2015 Jun 24. pii: S0002-9149(15)01532.
    PubMed     Text format     Abstract available


  104. WU MH, Chen HC, Kao FY, Huang SK, et al
    Risk of Systemic Hypertension and Cerebrovascular Accident in Patients With Aortic Coarctation Aged <60 Years (from a National Database Study).
    Am J Cardiol. 2015 Jun 4. pii: S0002-9149(15)01436.
    PubMed     Text format     Abstract available


    April 2015
  105. KABRA R, Cram P, Girotra S, Vaughan Sarrazin M, et al
    Effect of Race on Outcomes (Stroke and Death) in Patients >65 Years With Atrial Fibrillation.
    Am J Cardiol. 2015 Apr 16. pii: S0002-9149(15)01106.
    PubMed     Text format     Abstract available


  106. ZHANG X, Li Q, Rogatko A, Tighiouart M, et al
    Analysis of the bypass angioplasty revascularization investigation trial using a multistate model of clinical outcomes.
    Am J Cardiol. 2015;115:1073-9.
    PubMed     Text format     Abstract available


  107. MENNUNI MG, Halperin JL, Bansilal S, Schoos MM, et al
    Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
    Am J Cardiol. 2015 Apr 8. pii: S0002-9149(15)01039.
    PubMed     Text format     Abstract available


  108. SHIOMI H, Morimoto T, Furukawa Y, Nakagawa Y, et al
    Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Am J Cardiol. 2015 Apr 7. pii: S0002-9149(15)01046.
    PubMed     Text format     Abstract available


    March 2015
  109. JOHNSTON N, Jonelid B, Christersson C, Kero T, et al
    Effect of Gender on Patients With ST-Elevation and Non-ST-Elevation Myocardial Infarction Without Obstructive Coronary Artery Disease.
    Am J Cardiol. 2015 Mar 23. pii: S0002-9149(15)00961.
    PubMed     Text format     Abstract available


  110. PATTI G, Pelliccia F, Gaudio C, Greco C, et al
    Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.
    Am J Cardiol. 2015;115:837-43.
    PubMed     Text format     Abstract available


  111. PATEL AD, Tan MK, Angaran P, Bell AD, et al
    Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit).
    Am J Cardiol. 2015;115:641-6.
    PubMed     Text format     Abstract available


    February 2015
  112. DOMANSKI MJ, Farkouh ME, Zak V, Feske S, et al
    Predictors of Stroke Associated With Coronary Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease.
    Am J Cardiol. 2015 Feb 19. pii: S0002-9149(15)00729.
    PubMed     Text format     Abstract available


  113. WAKSMAN R, Pendyala LK
    Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
    Am J Cardiol. 2015;115:378-84.
    PubMed     Text format     Abstract available


  114. PATHAK R, Pandit A, Karmacharya P, Aryal MR, et al
    Meta-analysis on risk of bleeding with apixaban in patients with renal impairment.
    Am J Cardiol. 2015;115:323-7.
    PubMed     Text format     Abstract available


  115. WERNER N, Zeymer U, Hochadel M, Hauptmann KE, et al
    Fifteen-year experience with carotid artery stenting (from the carotid artery stenting-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte).
    Am J Cardiol. 2015;115:360-6.
    PubMed     Text format     Abstract available


  116. YOU JY, Chun EJ, Choi SI, Joe E, et al
    Clinical significance of incidentally detected aneurysms of the membranous ventricular septum in adults by multidetector computed tomography.
    Am J Cardiol. 2015;115:354-9.
    PubMed     Text format     Abstract available


    January 2015
  117. CHAMBERLAIN AM, Gersh BJ, Mills RM, Klaskala W, et al
    Antithrombotic Strategies and Outcomes in Acute Coronary Syndrome With Atrial Fibrillation.
    Am J Cardiol. 2015 Jan 31. pii: S0002-9149(15)00629.
    PubMed     Text format     Abstract available


  118. O'NEAL WT, Lakoski SG, Qureshi W, Judd SE, et al
    Relation Between Cancer and Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study).
    Am J Cardiol. 2015 Jan 31. pii: S0002-9149(15)00635.
    PubMed     Text format     Abstract available


  119. BARRETT TW, Storrow AB, Jenkins CA, Abraham RL, et al
    The AFFORD Clinical Decision Aid to Identify Emergency Department Patients With Atrial Fibrillation at Low Risk for 30-Day Adverse Events.
    Am J Cardiol. 2015 Jan 6. pii: S0002-9149(14)02318.
    PubMed     Text format     Abstract available


  120. PEGUERO JG, Issa O, Podesta C, Elmahdy HM, et al
    Usefulness of the CHADSVASc Score to Predict Postoperative Stroke in Patients Having Cardiac Surgery Independent of Atrial Fibrillation.
    Am J Cardiol. 2015 Jan 6. pii: S0002-9149(14)02319.
    PubMed     Text format     Abstract available


  121. KAESS BM, Ammar S, Reents T, Dillier R, et al
    Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon.
    Am J Cardiol. 2015;115:47-51.
    PubMed     Text format     Abstract available


  122. CALKINS H, Gerstenfeld EP, Schilling R, Verma A, et al
    RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy.
    Am J Cardiol. 2015;115:154-5.
    PubMed     Text format    


    December 2014
  123. GALASSO G, De Servi S, Savonitto S, Strisciuglio T, et al
    Effect of an Invasive Strategy on Outcome in Patients >/=75 Years of Age With Non-ST-Elevation Acute Coronary Syndrome.
    Am J Cardiol. 2014 Dec 18. pii: S0002-9149(14)02268.
    PubMed     Text format     Abstract available


  124. OTA T, Ishii H, Suzuki S, Tanaka A, et al
    Relation Between Paradoxical Decrease in High-Density Lipoprotein Cholesterol Levels After Statin Therapy and Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction.
    Am J Cardiol. 2014 Dec 17. pii: S0002-9149(14)02263.
    PubMed     Text format     Abstract available


    November 2014
  125. YARANOV DM, Smyrlis A, Usatii N, Butler A, et al
    Effect of Obstructive Sleep Apnea on Frequency of Stroke in Patients With Atrial Fibrillation.
    Am J Cardiol. 2014 Nov 29. pii: S0002-9149(14)02168.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: